Literature DB >> 33442430

How much platelet-rich plasma can be soak-loaded onto beta-tricalcium phosphate? A comparison with or without a unidirectional porous structure.

Norihito Arai1, Tomokazu Yoshioka1,2, Hisashi Sugaya1, Akihiro Kanamori1, Masashi Yamazaki1.   

Abstract

Objective: This study aimed to examine differences in platelet-rich plasma (PRP) soak-loaded volumes of β-tricalcium phosphate (β-TCP) with or without a unidirectional porous structure. Materials and
Methods: Leukocyte-rich PRP was extracted from 15 healthy volunteers by centrifugation. Two types of artificial bones were soaked for either ten seconds or ten minutes. The volume ratios of PRP soak-loaded onto the artificial bone and soaked area ratios were evaluated. Statistical analyses were performed using the Tukey-Kramer HSD test and the Games-Howell method. A P-value of <0.05 was considered statistically significant.
Results: Regardless of the soaking time, the PRP soak-loaded volume ratio and soaked area ratio were significantly higher in the unidirectional porous β-TCP (UDPTCP) group than in the spherical porous β-TCP (SPTCP) group.
Conclusion: PRP can be soak-loaded faster and in larger amounts onto UDPTCP compared to SPTCP. Understanding the basic biology of β-TCP soak-loaded with PRP can help develop more novel and effective β-TCP treatments for orthopedic surgery. ©2021 The Japanese Association of Rural Medicine.

Entities:  

Keywords:  artificial bone; loaded volume; platelet-rich plasma; unidirectional porous; β-tricalcium phosphate

Year:  2021        PMID: 33442430      PMCID: PMC7788299          DOI: 10.2185/jrm.2020-034

Source DB:  PubMed          Journal:  J Rural Med        ISSN: 1880-487X


Introduction

Currently, the most common treatment for bone defects is autologous bone grafting. However, this method has several limitations, including the amount of bone that can be harvested, the occurrence of pain at the harvest site, and other issues[1], [2]). Artificial bone, which has excellent osteo-conductivity and biocompatibility, is often used as a bone substitute for the reconstruction of large bones with defects and for spinal fusion[3]). However, because non-bone tissues are present in the surrounding area, various attempts have been made to promote osteoinduction in artificial bones to promote osteogenesis[4],[5],[6],[7],[8],[9],[10]). The diamond concept, which is used in bone regeneration, proposes four pillars for regenerative medicine using tissue engineering: mesenchymal stem cells, growth factors, scaffolds, and the mechanical environment[11]).Various tissue engineering methods using soak-loaded cells or growth factors on artificial bone scaffolds have been reported, yet no standard method for scaffold loading has been established. Intriguingly, cells induce osteogenesis when grafted porous artificial bone is soak-loaded with marrow-derived mesenchymal cells[5]). The clinical application of cultured autologous mesenchymal stem cells in bone regeneration has been discussed; however, the allogenic method is preferred because of its convenience, time availability, and cost-effectiveness[12]). Growth factors, especially bone morphogenetic proteins, are the most vital. Unidirectional porous hydroxyapatite (UDPHAp) can load a larger amount of rhBMP-2 and has a higher osteogenic capacity than interconnected calcium porous HAp ceramic (IP-CHA)[6]). However, the use of a high dose of BMP-2 in spine surgery results in ectopic bone formation[13]). This necessitates the use of autologous platelet-rich plasma with growth factors[14]). PRP is an autologous product obtained by centrifuging peripheral blood and subsequently separating and extracting the plasma layer, which contains a large amount of platelets. PRP is rich in growth factors involved in osteogenesis, including transforming growth factor-β (TGF-β)[14]). In in vitro studies, PRP is involved in bone regeneration where it improves osteoblast chemotaxis, promotes cell growth, and stimulates the autocrine secretion of angiogenic factors[15]). Additional administration of PRP after autologous bone grafts to mandibular defects promotes osteogenesis more than the autologous bone grafting alone, as evidenced through imaging and histological assessments[16]). UDPHAp can quickly absorb blood via the capillary phenomenon[17]), and in grafts of tibial defect models, the infiltration of osteoblasts, osteocytes, and capillaries into these pores contributes to the formation of new bone[18]). In recent years, unidirectional porous β-tricalcium phosphate (UDPTCP), which also has a unidirectional porous structure, has been developed. UDPTCP can induce osteogenesis as fast as UDPHAp in the same animal model with an improved balance of material absorption[19]). In grafts used at fibular resection sites in spinal surgeries, UDPTCP results in fewer residual bone defects than spherical porous β-TCP (SPTCP)[20]), and the absorption of the material and replacement with a new bone contribute to a strong recovery at the graft site[21], [22]). β-TCP plays a role in the scaffold and mechanical environment, while PRP plays a growth factor. We hypothesized that β-TCP soak-loaded with PRP would promote osteogenesis in bone defects, where there is little host bone, and in spinal surgery. We assumed that β-TCP induces osteoclast activity during the bone resorption process[23], [24]). Further, we believed that the growth factors contained in PRP would stimulate the proliferation, migration, and chemotaxis of osteoblasts[15]), which would promote osteogenesis. UDPTCP can be penetrated with PRP through the capillary phenomenon, whereas SPTCP can be filled through its spherical pores (Figure 1). Therefore, we investigated whether differences in the structure of β-TCP affect PRP soak-loaded volumes. To the best of our knowledge, this study is the first to quantify PRP soak-loaded onto UDPTCP.
Figure 1

Schematic drawings of soak-loaded PRP onto β-TCP.

Arrow shows the route through which blood cells enter the PRP. UDPTCP could be penetrated with PRP through the capillary phenomenon, whereas SPTCP could be filled through its spherical pores. β-TCP: β-tricalcium phosphate; PRP: platelet-rich plasma; UDPTCP: unidirectional porous β-TCP; SPTCP: spherical porous β-TCP.

Schematic drawings of soak-loaded PRP onto β-TCP. Arrow shows the route through which blood cells enter the PRP. UDPTCP could be penetrated with PRP through the capillary phenomenon, whereas SPTCP could be filled through its spherical pores. β-TCP: β-tricalcium phosphate; PRP: platelet-rich plasma; UDPTCP: unidirectional porous β-TCP; SPTCP: spherical porous β-TCP.

Materials and Methods

Ethical approval

All subjects enrolled in this study provided written informed consent. The study protocol was approved by the Institutional Committee on Human Research at the University of Tsukuba (approval no. 1312).

Subjects

Fourteen healthy volunteers (mean age, 33.4 years; range, 26–44 years) participated in the study. Inclusion criteria were as follows: Japanese men or women, over 20 years of age. Exclusion criteria were serious medical history, illness currently being treated, difficult blood sampling, and/or anemia.

PRP preparation

Eight milliliters of anticoagulant (Anticoagulant Citrate Dextrose Solution-A; Zimmer Biomet, Warsaw, Indiana, USA) was aspirated into a 60 ml syringe, and peripheral blood (52 mL) was collected from the median cubital vein using a 22 G winged needle. A GPS-III separation tube was filled with blood containing the anticoagulant (60 mL). The tube was centrifuged at 3,200 rpm for 15 min at 22–24°C using a GPS-III Platelet Concentration System (Zimmer Biomet, Warsaw, Indiana, USA). After removing the platelet-poor plasma (PPP), approximately 6 mL of PRP was extracted (Figure 2).
Figure 2

Centrifugation system.

a: Centrifugation at 3,200 rpm for 15 min using the single-spin system (GPS-III Platelet Concentration System; Zimmer Biomet). b: Platelet-rich plasma in GPS-III kit after centrifugation. Buffy-coat float above the red blood cell layer.

Centrifugation system. a: Centrifugation at 3,200 rpm for 15 min using the single-spin system (GPS-III Platelet Concentration System; Zimmer Biomet). b: Platelet-rich plasma in GPS-III kit after centrifugation. Buffy-coat float above the red blood cell layer.

Artificial bone

Affinos® (Kuraray Co., Ltd., Tokyo, Japan) was used as the UDPTCP and βbone60® (Zimmer Biomet GK) as the SPTCP. Pieces of UDPTCP and SPTCP that were 8 mm in diameter were used. Affinos® has 30-250 µm unidirectional pores[19]) and βbone60® has the same structure as OSferion60®, which consists of macropores ≥100 µm and micropores ≤5 µm[25]). These parameters meet the criteria to act as scaffold materials for bone regeneration[26]).

Soaking of artificial bone in PRP

The 6 mL of PRP that was extracted previously was dispensed into four individual 5 ml Eppendorf Tubes (Eppendorf) at 1.5 mL each. The two types of artificial bone were soaked for either 10 seconds or 10 minutes to make a total of four groups (UDTCP 10 seconds; U-10, UDPTCP 10 minutes; U-600, SPTCP 10 seconds; S-10, SPTCP 10 minutes; S-600). After soaking, PRP that adhered to the surface of the artificial bone was wiped with gauze moistened with physiological saline[27]), and the pieces were placed in vials (Vials With Screw Cap; Nichiden-Rika Glass Co. Ltd., Kobe, Hyogo, Japan) containing 2.5% glutaraldehyde (Wako, 20% glutaraldehyde solution diluted with 0.1 mol/L phosphate buffer pH 7.0).

Hematological assessment

Leukocyte and platelet counts of the peripheral blood and extracted PRP were measured with a cell count analyzer (Sysmex KX-21N; Sysmex Corp., Kobe, Japan) to calculate concentrations as follows. The PAW classification system was used for PRP[28]).

Porosity measurement

Gravimetry was used to calculate porosity[26], [29]). The mass of the artificial bone was measured on an electronic scale (AB204; Mettler Toledo) and the volume was calculated by measuring the distances from the four sides on photographs of artificial bone cross-sections taken to measure the soaked area. The density of the material was 3.07 mg/mm3, which is the theoretical density of β-TCP. The loaded volume capacity was calculated from the porosity obtained with the above formula. The calculations were performed by approximating the specific gravity of the serum and PRP to 1.03 (mg/mm3)[30]) and 1.03 mg/mm3, respectively. [loaded volume capacity (mg)] = [artificial bone volume (mm3)] × [porosity (%)] × 1.03 (mg/mm3)

Soak-loaded volume measurement

The mass was measured on an electronic scale (AB204; Mettler Toledo) and the soak-loaded volume ratio of artificial bone was measured as follows: [soak loaded volume of artificial bone (mg)] = [artificial bone in a vial with fixative after soaking with PRP (mg)] – [artificial bone before soaking (mg)] – [fixative (mg)] – [vial (mg)] The soak-loaded volume ratio was calculated as the ratio of the soak-loaded volume to the loaded volume capacity.

Soaked area measurement

The artificial bone was removed from the fixation tube and sliced using a cutting machine (ISOMET; Buehler, Illinois) parallel to the pores on a plane passing through the center of the cylinder. The cross-section was photographed (PL2; Olympus, Japan, NY1S-MOFA) and printed on high sensitivity paper 210 × 297 mm (A4). With the groups blinded, two investigators (TY, HS) traced the outline of the soaked area of the artificial bone in the photographs to create binary images with the soaked area in black and the non-soaked area in white[31]). The area of the cross-section and the soaked area were calculated using ImageJ to semi-quantitatively measure the soaked area ratio as follows:

Statistical analysis

All results are expressed as the mean ± standard deviation. Soak-loaded volume ratios were compared using the Tukey-Kramer HSD test, soak-loaded volumes and soaked area ratios with the Games-Howell method, and loaded volume capacities with Welch’s t-test. SPSS Statistics software version 25.0 (International Business Machines Co., New York City, NY, USA) was used to calculate statistics and P<0.05 was considered a significant difference.

Results

In the peripheral blood, the mean leukocyte count was 5.3 ± 1.2 × 103/μL and the mean platelet count was 21.3 ± 4.7 × 104/μL. In PRP, the mean leukocyte count was 28.1 ± 12.5 × 103/μL and the mean platelet count was 204.0 ± 111.1 × 104/µL. These values showed a leukocyte and platelet concentration of 5.5 and 9.3 times that of the peripheral blood, respectively (Figure 3). The PAW classification was P4-Aα.
Figure 3

Hematological analysis.

The concentration of leukocytes and platelets is 5.5 and 9.3 times that of the peripheral blood. Data are presented as the mean ± SD.

Hematological analysis. The concentration of leukocytes and platelets is 5.5 and 9.3 times that of the peripheral blood. Data are presented as the mean ± SD. Porosity calculated by gravimetry was 58.6 ± 2.1% for UDPTCP and 61.7 ± 3.2% for SPTCP, both of which are similar to the values provided by the companies (UDPTCP 57 ± 5%, SPTCP 60%). The PRP loaded volume capacity calculated from these porosity values was 245.3 ± 19.8 mg for UDPTCP and 265.0 ± 24.7 mg for SPTCP, with SPTCP being significantly higher (Figure 4).
Figure 4

Load volume capacity.

The loaded volume capacity of SPTCP was higher than that of UDPTCP (P<0.05). Data are presented as the mean ± SD.

Load volume capacity. The loaded volume capacity of SPTCP was higher than that of UDPTCP (P<0.05). Data are presented as the mean ± SD. The soak-loaded volumes were 189.5 ± 7.3 mg for U-10, 182.8 ± 8.3 mg for U-600, 91.7 ± 28.9 mg for S-10, and 120.0 ± 15.3 mg for S-600. When comparing the soaking times (U-10 vs. S-10, U-600 vs. S-600), UDPTCP was significantly higher than SPTCP. When comparing the artificial bone types, there was no significant difference between U-10 and U-600, although S-600 was significantly higher than S-10. The soak-loaded volume ratios were 75.6 ± 6.4% for U-10, 76.8 ± 4.9% for U-600, 34.0 ± 9.1% for S-10, and 46.0 ± 7.0% for S-600. When comparing U-10 to S-10 and U-600 to S-600, UDPTCP was significantly higher for both times. When comparing the artificial bone types, there was no significant difference between U-10 and U-600, although S-600 was significantly higher than S-10 (Figure 5).
Figure 5

Soak-loaded volume ratio.

The UDPTCP soak-loaded volume ratio was significantly higher than SPTCP (P<0.05). Data are presented as the mean ± SD.

Soak-loaded volume ratio. The UDPTCP soak-loaded volume ratio was significantly higher than SPTCP (P<0.05). Data are presented as the mean ± SD. The soaked area ratios were 100% for U-10 and U-600, 65.0 ± 5.4% for S-10, and 67.9 ± 9.1%. for S-600. When comparing the soaking times (U-10 vs. S-10, U-600 vs. S-600), UDPTCP was significantly higher. When comparing the artificial bone types, there were no significant differences between U-10 and U-600, or between S-10 and S-600 (Figure 6).
Figure 6

Soaked area ratio.

The UDPTCP soaked area ratio was significantly higher than SPTCP (P<0.05). Data are presented as the mean ± SD.

Soaked area ratio. The UDPTCP soaked area ratio was significantly higher than SPTCP (P<0.05). Data are presented as the mean ± SD.

Discussion

In this study, UDPTCP was able to soak-load PRP faster, and in larger amounts, than SPTCP. Previous studies have reported that loading β-TCP with PRP promotes osteogenesis[7], [8]). A histological study on the femoral bone defect mouse model confirmed that polycaprolactone-20% tricalcium phosphate (PCL-TCP) soak-loaded with 60 µL of leukocyte-poor PRP (LP-PRP) promoted osteogenesis after 12 weeks[7]). Radiographic and histological evaluations in a study on a radial defect rabbit model showed that SPTCP soak-loaded with bone marrow mesenchymal stem cells (BM-MSCs) and 200 µL of leukocyte-rich PRP (LR-PRP) promoted osteogenesis after both 4 and 8 weeks[8]). In addition, administering granulated artificial bone mixed with activated PRP promotes osteogenesis[9], [10]). In a study on a tibial fracture rabbit model, administering LR-PRP mixed with SPTCP promoted osteogenesis as seen through radiological, histological, and quantitative computed tomographic images after 12 weeks[9]). However, in an RCT of maxillary sinus defects, administration of β-TCP mixed with LP-PRP did not promote osteogenesis[10]). None of these studies quantified the amount of PRP that was loaded onto β-TCP. The PRP used in the present study was leukocyte-rich PRP, which was classified as P4-Aα according to PAW classification, and was obtained using a GPS-III system. In previous reports, PRP prepared from GPS-III systems had leukocyte concentrations of 3–5 times and platelet concentrations of 3–8 times those of the peripheral blood[32],[33],[34],[35]), which are similar to our results (Table 1). Marx et al.[14]) reported on PRP therapy for mandibular bone defects, stating that platelet counts of 100 × 104/µL and concentrations of 4–5 times that of the peripheral blood were the minimum necessary conditions to promote osteogenesis. The PRP used in the present study met these criteria.
Table 1

PRP concentration rates with the GPS-III system

FitzpatrickCastilloSundmanEppleyPresent study
Leukocyte concentration3-55.44.25.45.5
Platelet concentration3-62.13.88.19.3

PRP: Platelet-rich plasma.

PRP: Platelet-rich plasma. The loaded volume capacity of artificial bone in a cylinder (8 mm in diameter by 8 mm in length) was significantly higher with SPTCP than with UDPTCP. Therefore, to compare PRP soak-loaded volumes based on the presence or absence of a unidirectional porous structure and different soaking times, we did not calculate soak-loaded volume but rather the soak-loaded volume ratio, and not the soaked area but the soaked area ratio. The higher soak-loaded volume ratios regardless of soaking time suggest that the capillarity phenomenon created by the unidirectional porous structure[19]) enabled a large amount of PRP to be loaded in a short time. The fact that soak-loaded volume ratios reached a maximum at 75–77% may indicate that, because PRP was in a liquid state, some of it leaked from the pores when the artificial bone was removed from the PRP. Regarding the soaked area in the cross-section, PRP soaked the UDPTCP cross-section uniformly, indicating that the pores were filled with PRP during soaking. In contrast, the soak-loaded volume ratio of SPTCP was lower than 50%, even after soaking for 10 minutes, and penetration at the center of the cross-sections ceased at approximately 65–68%. These results show that PRP did not reach deeply into SPTCP, which may be due to differences in the structures of β-TCP[6]) and interference of air remaining in the pores[36]). The significantly higher soak-loaded volume ratio of S-600 compared with S-10 suggests that more PRP can be soak-loaded onto SPTCP if it is soaked for a longer time. However, PRP reportedly releases 70% of its growth factors 10 min after activation and 100% 1 hour after activation[28]). Once the β-TCP is soaked with PRP, PRP may be activated and transformed into a gel after 10 min. Thereafter, platelets cannot reach deep into the β-TCP. Therefore, when using artificial bone soak-loaded with PRP in clinical practice, it would be desirable to quickly load and administer the artificial bone with PRP. The soak-loaded volume of U-10 was significantly higher than that of S-600, which indicates that, since UDPTCP can be soak-loaded with PRP faster and in larger amounts than SPTCP, it could serve as a novel osteogenic composite. This study has some limitations. First, this study did not evaluate osteogenesis in vivo. It is important to evaluate whether the rate of PRP loading onto the β-TCP affects its osteo-inductive activity. Further studies are needed to evaluate bone union by comparing UDPTCP and SPTCP soak-loaded with PRP in vivo, such as in a lumbar interbody fusion cage. Second, the number of platelets and the amount of growth factors that were loaded are unknown. Platelets (2 µm in diameter) are smaller than red blood cells (RBCs; 7 µm in diameter)[30]). The soaked area in the cross-section appeared red, suggesting the presence of RBCs; therefore, loaded platelets may be present in the soaked area. In addition to the quantitative studies of PRP, further studies are needed to investigate which growth factors, and at what concentration, are effective for osteogenesis.

Conclusion

UDPTCP can soak-load PRP faster and in larger amounts than SPTCP. Further studies are necessary to determine the optimal PRP concentration that promotes bone formation. The basic data from our study could be used as a baseline for future clinical applications and studies in orthopedic surgery such as lumbar interbody fusion and nonunion surgeries.

Conflict of interests

One author is affiliated with the Department of Regenerative Medicine for Musculoskeletal System, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan. This department is an endowment department, supported by an unrestricted grant from Zimmer Biomet GK. No commercial party has a direct financial interest in the results of the research. Supporting this article has or will confer a benefit to the other authors or on any organization with which the other authors are associated.
  32 in total

1.  Efficient cell-seeding into scaffolds improves bone formation.

Authors:  T Hasegawa; M Miwa; Y Sakai; T Niikura; S Y Lee; K Oe; T Iwakura; M Kurosaka; T Komori
Journal:  J Dent Res       Date:  2010-06-08       Impact factor: 6.116

2.  Current trends in bone grafting and the issue of banked bone allografts based on the fourth nationwide survey of bone grafting status from 2000 to 2004.

Authors:  Ken Urabe; Moritoshi Itoman; Yoshiaki Toyama; Yoshiaki Yanase; Yukihide Iwamoto; Hajime Ohgushi; Mitsuo Ochi; Yoshinori Takakura; Yudo Hachiya; Hiromi Matsuzaki; Yoshitaka Matsusue; Satoshi Mori
Journal:  J Orthop Sci       Date:  2007-11-30       Impact factor: 1.601

Review 3.  Osteoinductive biomaterials: current knowledge of properties, experimental models and biological mechanisms.

Authors:  Ana M C Barradas; Huipin Yuan; Clemens A van Blitterswijk; Pamela Habibovic
Journal:  Eur Cell Mater       Date:  2011-05-15       Impact factor: 3.942

4.  A unidirectional porous beta-tricalcium phosphate material (Affinos®) for reconstruction of bony defects after excision of fibular bone for spinal surgery graft.

Authors:  Hiroshi Noguchi; Toru Funayama; Masao Koda; Yasushi Iijima; Hiroshi Kumagai; Tetsuhiro Ishikawa; Atsuomi Aiba; Tetsuya Abe; Katsuya Nagashima; Kousei Miura; Shigeo Izawa; Satoshi Maki; Takeo Furuya; Masashi Yamazaki
Journal:  J Clin Neurosci       Date:  2019-06-04       Impact factor: 1.961

5.  Growth factor and catabolic cytokine concentrations are influenced by the cellular composition of platelet-rich plasma.

Authors:  Emily A Sundman; Brian J Cole; Lisa A Fortier
Journal:  Am J Sports Med       Date:  2011-08-16       Impact factor: 6.202

6.  Bone formation and resorption in patients after implantation of beta-tricalcium phosphate blocks with 60% and 75% porosity in opening-wedge high tibial osteotomy.

Authors:  Takaaki Tanaka; Yoshio Kumagae; Mitsuru Saito; Masaaki Chazono; Hirokazu Komaki; Takahiro Kikuchi; Seiichiro Kitasato; Keishi Marumo
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2008-08       Impact factor: 3.368

7.  Polycaprolactone-20% tricalcium phosphate scaffolds in combination with platelet-rich plasma for the treatment of critical-sized defects of the mandible: a pilot study.

Authors:  Bina Rai; Kee Hai Ho; Yang Lei; Kuan-Ming Si-Hoe; Choon-Mengjeremy Jeremy Teo; Kamal Bin Yacob; Fulin Chen; Fooi-Chin Ng; Swee Hin Teoh
Journal:  J Oral Maxillofac Surg       Date:  2007-11       Impact factor: 1.895

Review 8.  The biology of platelet-rich plasma and its application in trauma and orthopaedic surgery: a review of the literature.

Authors:  J Alsousou; M Thompson; P Hulley; A Noble; K Willett
Journal:  J Bone Joint Surg Br       Date:  2009-08

9.  Application of Platelet-rich Plasma and Tricalcium Phosphate in the Treatment of Comminuted Fractures in Animals.

Authors:  Tomasz Szponder; Joanna Wessely-Szponder; Aleksandra Sobczyńska-Rak; Beata Żylińska; Radosław P Radzki; Izabella Polkowska
Journal:  In Vivo       Date:  2018 Nov-Dec       Impact factor: 2.155

10.  Analysis of Platelet-Rich Plasma Extraction: Variations in Platelet and Blood Components Between 4 Common Commercial Kits.

Authors:  Jane Fitzpatrick; Max K Bulsara; Paul Robert McCrory; Martin D Richardson; Ming Hao Zheng
Journal:  Orthop J Sports Med       Date:  2017-01-03
View more
  1 in total

Review 1.  Unidirectional porous beta-tricalcium phosphate and hydroxyapatite artificial bone: a review of experimental evaluations and clinical applications.

Authors:  Toru Funayama; Hiroshi Noguchi; Hiroshi Kumagai; Kosuke Sato; Tomokazu Yoshioka; Masashi Yamazaki
Journal:  J Artif Organs       Date:  2021-04-23       Impact factor: 1.731

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.